87
Views
73
CrossRef citations to date
0
Altmetric
Review

The epidemiology of psoriasis

, &
Pages 63-75 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Franziska Stenger, Anke König, Falk Ochsendorf, Roland Kaufmann & Andreas Pinter. (2021) Correct performance of subcutaneous injections in plaque psoriasis: comparison of trained and untrained patients with different application systems in routine clinical care. Journal of Dermatological Treatment 32:8, pages 898-906.
Read now
Anwar Al Hammadi, Afaf Al-Sheikh, Alfred Ammoury, Samer Ghosn, Paolo Gisondi, Issam Hamadah, Abdul-Ghani Kibbi & Khalid Shirazy. (2017) Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region. Journal of Dermatological Treatment 28:2, pages 129-135.
Read now
Jacek Karczewski, Agnieszka Dobrowolska, Anna Rychlewska-Hańczewska & Zygmunt Adamski. (2016) New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis. Autoimmunity 49:7, pages 435-450.
Read now
. (2010) Invited Speakers. Drug Metabolism Reviews 42:sup1, pages 1-323.
Read now
Shanu Kohli Kurd, Stephen K Richardson & Joel M Gelfand. (2007) Update on the epidemiology and systemic treatment of psoriasis. Expert Review of Clinical Immunology 3:2, pages 171-185.
Read now

Articles from other publishers (68)

Ratnam Sreya, Shweta Nene, Vrushali Pathade, Shashi Bala Singh & Saurabh Srivastava. (2023) Emerging trends in combination strategies with phototherapy in advanced psoriasis management. Inflammopharmacology 31:4, pages 1761-1778.
Crossref
Majed M. Khraishi, Valencia P. Remple, Samuel Silverberg, Jacqueline C. Stewart, Brandusa Florica & Louis Bessette. (2022) Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs. The Journal of Rheumatology 49:5, pages 454-464.
Crossref
Bruno Halioua, Clara Chelli, Laurent Misery, Jonathan Taieb & Charles Taieb. (2022) Sleep Disorders and Psoriasis: An Update. Acta Dermato-Venereologica 102, pages adv00699.
Crossref
Fahimeh Nourbakhsh, Seyed Hadi Mousavi, Pouria Rahmanian-Devin, Vafa Baradaran Rahimi, Hassan Rakhshandeh & Vahid Reza Askari. (2022) Topical Formulation of Noscapine, a Benzylisoquinoline Alkaloid, Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-19.
Crossref
Marta Wacewicz-Muczyńska, Katarzyna Socha, Jolanta Soroczyńska, Marek Niczyporuk & Maria H. Borawska. (2021) Cadmium, lead and mercury in the blood of psoriatic and vitiligo patients and their possible associations with dietary habits. Science of The Total Environment 757, pages 143967.
Crossref
Harsha Jain, Aditi Rajan Bhat, Harshita Dalvi, Chandraiah Godugu, Shashi Bala Singh & Saurabh Srivastava. (2021) Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment. Current Research in Pharmacology and Drug Discovery 2, pages 100041.
Crossref
Ashwin Anandan, Ravindraprasad Thokala, Krishnamoorthy Radhakrishnan, Vinod Kumar Panicker & Murugan Sundaram. (2020) HLA- A & B Association in Psoriasis in Tamil Speaking South Indian Population. Journal of Evolution of Medical and Dental Sciences 9:23, pages 1782-1786.
Crossref
Tasneem Gul Kazi, Suraya Samejo, Hassan Imran Afridi, Asma Akhtar & Jameel Ahmed Baig. (2019) A switchable ionic liquid with polarity swing‐assisted regeneration properties used for the preconcentration of cadmium in biological samples. Applied Organometallic Chemistry 34:1.
Crossref
Suraya Samejo, Atif G. Kazi, Hassan I. Afridi & Tasneem G. Kazi. (2019) Evaluate the effect of cadmium on levels of zinc in scalp hair and blood samples of smoker and nonsmoker psoriatic patients at different stage. Environmental Science and Pollution Research 26:31, pages 31763-31769.
Crossref
Amit Kumar Roy, Fahad Al Basir & Priti Kumar Roy. (2019) A vivid cytokines interaction model on psoriasis with the effect of impulse biologic ( inhibitor) therapy . Journal of Theoretical Biology 474, pages 63-77.
Crossref
Miguel Alpalhão, J. Borges-Costa & Paulo Filipe. (2019) Psoriasis in HIV infection: an update. International Journal of STD & AIDS 30:6, pages 596-604.
Crossref
Simin Lesan, Roja Toosi, Reza Aliakbarzadeh, Maryam Daneshpazhooh, Leila Mahmoudi, Soheil Tavakolpour & Hamidreza Mahmoudi. (2018) Oral Candida colonization and plaque type psoriasis: Is there any relationship?. Journal of Investigative and Clinical Dentistry 9:3, pages e12335.
Crossref
Nawaf Al Mutairi, Dhuha Alrqobah & Nasser Haji Hussain. (2018) Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents. Dermatologic Therapy 31:1, pages e12566.
Crossref
Marta Wacewicz, Katarzyna Socha, Jolanta Soroczyńska, Marek Niczyporuk, Piotr Aleksiejczuk, Jolanta Ostrowska & Maria H. Borawska. (2017) Concentration of selenium, zinc, copper, Cu/Zn ratio, total antioxidant status and c-reactive protein in the serum of patients with psoriasis treated by narrow-band ultraviolet B phototherapy: A case-control study. Journal of Trace Elements in Medicine and Biology 44, pages 109-114.
Crossref
Hız Meliha Merve, Kılıç Sevilay, Oymak Sibel, Büyük Başak, Canbey Göret Ceren, Tuba Demirci & Akı Cüneyt. 2017. An Interdisciplinary Approach to Psoriasis. An Interdisciplinary Approach to Psoriasis.
U. Mrowietz, J.C. Szepietowski, R. Loewe, P. van de Kerkhof, R. Lamarca, W.G. Ocker, V.M. Tebbs & I. Pau-Charles. (2017) Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm ® - and placebo-controlled trial (BRIDGE) . British Journal of Dermatology 176:3, pages 615-623.
Crossref
Reza M. Robati, Masoud Partovi-Kia, Hadi Sadat-Amini, Hamid Reza Haghighatkhah, Shima Younespour & Parviz Toossi. (2016) Serum osteopontin level and common carotid artery intima-media wall thickness in psoriasis. International Journal of Dermatology 55:5, pages e262-e267.
Crossref
Max M. Benson & William H. Frishman. (2015) The Heartbreak of Psoriasis. Cardiology in Review 23:6, pages 312-316.
Crossref
April N. Naegeli, Emuella Flood, Jennifer Tucker, Jennifer Devlen & Emily Edson-Heredia. (2015) The Worst Itch Numeric Rating Scale for patients with moderate to severe plaque psoriasis or psoriatic arthritis. International Journal of Dermatology 54:6, pages 715-722.
Crossref
Giulia Ganzetti. (2015) Non-alcoholic fatty liver disease and psoriasis: So far, so near. World Journal of Hepatology 7:3, pages 315.
Crossref
B.E. Strober, Y. Poulin, C. Teller, Y. Wang, D.A. Williams & O.M. Goldblum. (2014) Changes in C-reactive protein in patients with moderate-to-severe psoriasis switched to adalimumab therapy after suboptimal response to etanercept, methotrexate or phototherapy. Journal of the European Academy of Dermatology and Venereology 28:12, pages 1701-1706.
Crossref
Jacek Karczewski, Barbara Poniedziałek, Piotr Rzymski & Zygmunt Adamski. (2014) Factors affecting response to biologic treatment in psoriasis. Dermatologic Therapy 27:6, pages 323-330.
Crossref
F. Maunoury, A. Motrunich, B. Halioua, A. de Fontaubert, Agathe Maury Le Breton, François Dogniaux, ME. Roussel & JF Stalder. (2014) Coûts annuels de prise en charge des patients atteints de psoriasis traités par topiques en France. Journal de gestion et d'économie médicales Vol. 31:7, pages 457-472.
Crossref
H. Zafar, J. Enfield, M. -L. O'Connell, B. Ramsay, M. Lynch & M. J. Leahy. (2014) Assessment of psoriatic plaque in vivo with correlation mapping optical coherence tomography . Skin Research and Technology 20:2, pages 141-146.
Crossref
Ahmad HaniAhmad Hani & Esa Prakasa. 2014. Surface Imaging for Biomedical Applications. Surface Imaging for Biomedical Applications 51 86 .
Tiago Torres & Nuno Bettencourt. (2014) Psoriasis: The visible killer. Revista Portuguesa de Cardiologia (English Edition) 33:2, pages 95-99.
Crossref
Tiago Torres & Nuno Bettencourt. (2014) Psoriasis: The visible killer. Revista Portuguesa de Cardiologia 33:2, pages 95-99.
Crossref
Emily Edson-Heredia, Kimberly L. Sterling, Carlos I. Alatorre, Gebra Cuyun Carter, Rosirene Paczkowski, Victoria Zarotsky & Tomoko Maeda-Chubachi. (2014) Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis. Journal of Investigative Dermatology 134:1, pages 18-23.
Crossref
Ann G. Coumbe, Marc R. Pritzker & Daniel A. Duprez. (2014) Cardiovascular Risk and Psoriasis: Beyond the Traditional Risk Factors. The American Journal of Medicine 127:1, pages 12-18.
Crossref
M. Hani Ahmad Fadzil, Esa Prakasa, Vijanth Sagayan Asirvadam, Hermawan Nugroho, Azura Mohd Affandi & Suraiya Hani Hussein. (2013) 3D surface roughness measurement for scaliness scoring of psoriasis lesions. Computers in Biology and Medicine 43:11, pages 1987-2000.
Crossref
Baojin Zhu, Emily Edson-Heredia, Jennifer L. Gatz, Jiaying Guo & Catherine L. Shuler. (2013) Treatment Patterns and Health Care Costs for Patients With Psoriatic Arthritis on Biologic Therapy: A Retrospective Cohort Study. Clinical Therapeutics 35:9, pages 1376-1385.
Crossref
Jau-Jiuan Sheu, Kuo-Hsien Wang, Herng-Ching Lin & Chung-Chien Huang. (2013) Psoriasis is associated with an increased risk of parkinsonism: A population-based 5-year follow-up study. Journal of the American Academy of Dermatology 68:6, pages 992-999.
Crossref
Shreya Dixit, Stephen Shumack & Gayle Fischer. (2013) Letter to the Editor. Australasian Journal of Dermatology 54:2, pages 147-147.
Crossref
Amy Boardman. (2013) A Practical Approach to Vulvar Pruritus and the Vulvar Dermatoses. Postgraduate Obstetrics & Gynecology 33:7, pages 1-5.
Crossref
Rosa Parisi, Deborah P.M. Symmons, Christopher E.M. Griffiths & Darren M. Ashcroft. (2013) Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. Journal of Investigative Dermatology 133:2, pages 377-385.
Crossref
P.B. Wilson, K.A. Bohjanen, S.J. Ingraham & A.S. Leon. (2012) Psoriasis and physical activity: a review. Journal of the European Academy of Dermatology and Venereology 26:11, pages 1345-1353.
Crossref
Shivam Kapila, Jennifer Bradford & Gayle Fischer. (2012) Vulvar Psoriasis in Adults and Children. Journal of Lower Genital Tract Disease 16:4, pages 364-371.
Crossref
Sangai Palanisamy Dhanabal, Nithyanantham Muruganantham, Kabbur Hanumanthappa Basavaraj, Asish Wadhwani & Nonavinakere Mannar Shamasundar. (2012) Antipsoriatic activity of extracts and fractions obtained from Memecylon malabaricum leaves . Journal of Pharmacy and Pharmacology 64:10, pages 1501-1509.
Crossref
Harris Allen, William B. Bunn & Ahmad B. Naim. (2012) The Self-Reported Health and Productivity Burden of Autoimmune Disorders at a Major Self-Insured Employer. Journal of Occupational & Environmental Medicine 54:9, pages 1049-1063.
Crossref
Noori Kim & Alice B. Gottlieb. (2012) Psoriasis: Ustekinumab and Other Biologics in the Pipeline. Current Dermatology Reports 1:3, pages 108-114.
Crossref
Fernando Valenzuela, Yesenia Valenzuela & Viviana Zemelman. (2012) Epidemiological survey of psoriasis in the Chilean Mapuche population. International Journal of Dermatology 51:8, pages 1005-1006.
Crossref
A. F. M. Hani, E. Prakasa, H. Nugroho, A. M. Affandi & S. H. Hussein. (2012) Body surface area measurement and soft clustering for PASI area assessment. Body surface area measurement and soft clustering for PASI area assessment.
M. Augustin, J.M. Alvaro-Gracia, M. Bagot, O. Hillmann, P.C.M. van de Kerkhof, G. Kobelt, M. Maccarone, L. Naldi & H. Schellekens. (2012) A framework for improving the quality of care for people with psoriasis. Journal of the European Academy of Dermatology and Venereology 26, pages 1-16.
Crossref
Ahmad Fadzil M Hani, Esa Prakasa, Hermawan Nugroho, Azura Mohd Affandi & Suraiya H Hussein. (2012) Sample area for surface roughness determination of skin surfaces. Sample area for surface roughness determination of skin surfaces.
Shashi Amur, Ameeta Parekh & Padmaja Mummaneni. (2012) Sex differences and genomics in autoimmune diseases. Journal of Autoimmunity 38:2-3, pages J254-J265.
Crossref
Sungwon Lee & Jashin J. Wu. (2012) A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis. Current Dermatology Reports 1:1, pages 14-22.
Crossref
D. Kadry & L. Rashed. (2012) Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology 26:1, pages 66-70.
Crossref
Hyuck Hoon Kwon, In Ho Kwon & Jai Il Youn. (2012) Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?. International Journal of Dermatology 51:1, pages 53-58.
Crossref
Elizabeth Guihen, Wen Lyn Ho, Anna-Marie Hogan, Marie-Louise O’Connell, Martin J. Leahy, Bart Ramsay & William T. O’Connor. (2012) Rapid quantification of histamine in human psoriatic plaques using microdialysis and ultra high performance liquid chromatography with fluorescence detection. Journal of Chromatography B 880, pages 119-124.
Crossref
Kai Li & April W. Armstrong. (2012) A Review of Health Outcomes in Patients with Psoriasis. Dermatologic Clinics 30:1, pages 61-72.
Crossref
K. Abuabara, H. Lee & A.B. Kimball. (2011) The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study. British Journal of Dermatology 165:5, pages 1066-1073.
Crossref
M Abdulghani, A Al Sheik, M Alkhawajah, A Ammoury, F Behrens, H Benchikhi, I Benkaidali, N Doss, A El Gendy, I Mokhtar, D Odendaal, N Raboobee, D Thaçi, R Weiss & D Whitaker. (2011) Management of Psoriasis in Africa and the Middle East: A Review of Current Opinion, Practice and Opportunities for Improvement. Journal of International Medical Research 39:5, pages 1573-1588.
Crossref
Ahmad Fadzil M. Hani, Esa Prakasa, Hurriyatul Fitriyah, Hermawan Nugroho, Azura Mohd Affandi & Suraiya Hani Hussein. 2011. Visual Informatics: Sustaining Research and Innovations. Visual Informatics: Sustaining Research and Innovations 341 351 .
E.D. Dommasch, D.B. Shin, A.B. Troxel, D.J. Margolis & J.M. Gelfand. (2010) Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis. British Journal of Dermatology 162:4, pages 835-842.
Crossref
Nawaf AL‐MUTAIRI, Shahat AL‐FARAG, Ahmed AL‐MUTAIRI & Mazen AL‐SHILTAWY. (2010) Comorbidities associated with psoriasis: An experience from the Middle East. The Journal of Dermatology 37:2, pages 146-155.
Crossref
Lloyd J. Cleaver, Nathan Cleaver & Katherine Johnson. 2010. Challenging Cases in Allergic and Immunologic Diseases of the Skin. Challenging Cases in Allergic and Immunologic Diseases of the Skin 267 285 .
J Xiao, L-H Chen, Y-T Tu, X-H Deng & J Tao. (2009) Prevalence of myocardial infarction in patients with psoriasis in central China. Journal of the European Academy of Dermatology and Venereology 23:11, pages 1311-1315.
Crossref
Slavenka JANKOVIC, Milena RAZNATOVIC, Jelena MARINKOVIC, Janko JANKOVIC & Natasa MAKSIMOVIC. (2009) Risk factors for psoriasis: A case-control study. The Journal of Dermatology 36:6, pages 328-334.
Crossref
Shanu Kohli Kurd & Joel M. Gelfand. (2009) The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004. Journal of the American Academy of Dermatology 60:2, pages 218-224.
Crossref
Manette T. Niu, Robert Ball, Emily Jane Woo, Dale R. Burwen, Maureen Knippen & M. Miles Braun. (2009) Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007. Vaccine 27:2, pages 290-297.
Crossref
M. H. Ahmad Fadzil, Hurriyatul Fitriyah, Esa Prakasa, Hermawan Nugroho, S. H. Hussein & Azura Mohd. Affandi. 2009. Visual Informatics: Bridging Research and Practice. Visual Informatics: Bridging Research and Practice 448 454 .
Joseph F. Fowler, Mei Sheng Duh, Ludmila Rovba, Sharon Buteau, Lisa Pinheiro, Francis Lobo, Jennifer Sung, Joseph J. Doyle, Andrine Swensen, David A. Mallett & George Kosicki. (2008) The impact of psoriasis on health care costs and patient work loss. Journal of the American Academy of Dermatology 59:5, pages 772-780.
Crossref
F. Späh. (2008) Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. British Journal of Dermatology 159, pages 10-17.
Crossref
V E Garcia, M Chang, R Brandon, Y Li, N Matsunami, K P Callis-Duffin, D Civello, C M Rowland, N Bui, J J Catanese, G G Krueger, M F Leppert, A B Begovich & S J Schrodi. (2008) Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes & Immunity 9:6, pages 546-555.
Crossref
Rahat S Azfar & Joel M Gelfand. (2008) Psoriasis and metabolic disease: epidemiology and pathophysiology. Current Opinion in Rheumatology 20:4, pages 416-422.
Crossref
M Chang, Y Li, C Yan, K P Callis-Duffin, N Matsunami, V E Garcia, M Cargill, D Civello, N Bui, J J Catanese, M F Leppert, G G Krueger, A B Begovich & S J Schrodi. (2007) Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes & Immunity 9:2, pages 176-181.
Crossref
Andrea L. Neimann, Daniel B. Shin, Xingmei Wang, David J. Margolis, Andrea B. Troxel & Joel M. Gelfand. (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. Journal of the American Academy of Dermatology 55:5, pages 829-835.
Crossref
Kenneth A. Katz, Jason H. Karlawish, David S. Chiang, Rachel A. Bognet, Katherine J. Propert & David J. Margolis. (2006) Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: A cross-sectional study. Journal of the American Academy of Dermatology 55:5, pages 814-822.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.